The role of urinary alkaliniser, potassium citrate in treatment of pediatric (aged 1 month to 18 years old) UTIs and to compare the outcomes in term of duration of hospital stay, time to achieve resolution of the symptoms and change in clinical septic parameters with placebo group (drinking water)

niversiti Sains Malaysia0 个研究点目标入组 60 人开始时间: 2023年2月7日最近更新: 2024年7月15日

适应症

试验速览

暂无简介。

•Age 1 month to 18 years old at diagnosis
•All inpatients diagnosed with acute UTI or/and recurrent UTI during their first or subsequent visit to hospital
•; •Age 1 month to 18 years old at diagnosis
•All inpatients diagnosed with acute UTI or/and recurrent UTI during their first or subsequent visit to hospital

•Patient who had been treated with antibiotics less than 72 hours before presentation
•Patient who is allergic to potassium citrate
•Patient with underlying chronic renal failure, untreated Addison disease as well as patient who is on potassium sparing agent
•Patient who previously already recruited in the study
•; •Patient who had been treated with antibiotics less than 72 hours before presentation
•Patient who is allergic to potassium citrate
•Patient with underlying chronic renal failure, untreated Addison disease as well as patient who is on potassium sparing agent
•Patient who previously already recruited in the study

发起方

niversiti Sains Malaysia